Quarterly report pursuant to Section 13 or 15(d)

SCHEDULE OF STOCK OPTIONS ACTIVITY (Details)

v3.21.2
SCHEDULE OF STOCK OPTIONS ACTIVITY (Details)
9 Months Ended
Sep. 30, 2021
$ / shares
shares
Compensation Related Costs [Abstract]  
Number of Options Outstanding, Beginning Balance | shares
Weighted Average Exercise Price Per Share, Beginning Balance | $ / shares
Number of Options Granted | shares 450,000
Weighted Average Exercise Price Per Share, Granted | $ / shares $ 1.38
Number of Options Outstanding, Ending Balance | shares 450,000
Weighted Average Exercise Price Per Share, Beginning Balance | $ / shares $ 1.38
Weighted Average Remaining Contractual Term, Outstanding 4 years 9 months 18 days
Number of Options Exercisable | shares 175,000
Weighted Average Exercise Price Per Share, Exercisable | $ / shares $ 2.22
Weighted Average Remaining Contractual Term, Exercisable 4 years 9 months 18 days
Number of Options Outstanding, Vested and Expected to Vest | shares 450,000
Weighted Average Exercise Price Per Share, Vested and Expected to Vest | $ / shares $ 1.38
Weighted Average Remaining Contractual Term, Vested and Expected to Vest 4 years 9 months 18 days